THYROCARE

Thyrocare Technologies Share Price

₹983.65 +20.5 (2.13%)

21 Nov, 2024 14:00

SIP TrendupStart SIP in THYROCARE

Start SIP

Performance

  • Low
  • ₹949
  • High
  • ₹990
  • 52 Week Low
  • ₹535
  • 52 Week High
  • ₹1,004
  • Open Price₹949
  • Previous Close₹963
  • Volume56,306

Investment Returns

  • Over 1 Month + 11.54%
  • Over 3 Month + 11.18%
  • Over 6 Month + 52.81%
  • Over 1 Year + 83.48%
SIP Lightning

Smart Investing Starts Here Start SIP with Thyrocare Technologies for Steady Growth!

Invest Now

Thyrocare Technologies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 62.1
  • PEG Ratio
  • 2.1
  • Market Cap Cr
  • 5,211
  • P/B Ratio
  • 9.9
  • Average True Range
  • 43.11
  • EPS
  • 15.85
  • Dividend Yield
  • 1.8
  • MACD Signal
  • 29.2
  • RSI
  • 57.75
  • MFI
  • 45.32

Thyrocare Technologies Financials

Thyrocare Technologies Technicals

EMA & SMA

Current Price
₹983.65
+ 20.5 (2.13%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹944.08
  • 50 Day
  • ₹896.14
  • 100 Day
  • ₹837.10
  • 200 Day
  • ₹761.98

Resistance and Support

971.53 Pivot Speed
  • R3 1,039.87
  • R2 1,019.88
  • R1 991.52
  • S1 943.17
  • S2 923.18
  • S3 894.82

What's your outlook on Thyrocare Technologies?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Thyrocare Technologies Ltd. is one of India’s leading diagnostic and preventive healthcare service providers, specializing in affordable and reliable pathology tests, including thyroid, diabetes, and wellness profiles, with a nationwide network of diagnostic labs and collection centers.

Thyrocare Technologies has an operating revenue of Rs. 623.26 Cr. on a trailing 12-month basis. An annual revenue growth of 9% is good, Pre-tax margin of 17% is great, ROE of 13% is good. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 9% and 32% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 3% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 56 which is a POOR score indicating inconsistency in earnings, a RS Rating of 81 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 31 indicates it belongs to a strong industry group of Medical-Services and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Thyrocare Technologies Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-23 Quarterly Results
2024-07-23 Quarterly Results
2024-05-14 Audited Results & Final Dividend
2024-02-01 Quarterly Results
2023-10-31 Quarterly Results
Date Purpose Remarks
2024-08-16 FINAL Rs.18.00 per share(180%)Final Dividend
2023-04-20 INTERIM Rs.18.00 per share(180%)Interim Dividend
2022-05-12 FINAL Rs.15.00 per share(150%)Interim Dividend

Thyrocare Technologies F&O

Thyrocare Technologies Shareholding Pattern

71.11%
12.9%
1.08%
1.93%
0%
9.78%
3.2%

About Thyrocare Technologies

  • NSE Symbol
  • THYROCARE
  • BSE Symbol
  • 539871
  • Managing Director & CEO
  • Mr. Rahul Guha
  • ISIN
  • INE594H01019

Similar Stocks to Thyrocare Technologies

Thyrocare Technologies FAQs

Thyrocare Technologies share price is ₹983 As on 21 November, 2024 | 13:46

The Market Cap of Thyrocare Technologies is ₹5210.6 Cr As on 21 November, 2024 | 13:46

The P/E ratio of Thyrocare Technologies is 62.1 As on 21 November, 2024 | 13:46

The PB ratio of Thyrocare Technologies is 9.9 As on 21 November, 2024 | 13:46

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23